Answers are grounded in this paper and cite their sources.
This retrospective study assessed changes in acute mastoiditis (AM) incidence, bacteriology, and complications after pneumococcal conjugate vaccine (PCV)-7 and PCV-13 introduction at Children’s Hospital of Michigan, Detroit, from 2000 to 2018. In this review of 242 children with AM, 138 cases occurred during PCV-7 use (2000-2010) and 104 during PCV-13 use (2011-2018). Incidence did not change after PCV-13 introduction ( P = .31). Streptococcus pneumoniae remained the predominant pathogen in both periods ( P = .375), while Streptococcus pyogenes infections increased during PCV-13 era, affecting older children (median age, 87.5 vs 30.0 months for S pneumoniae ). Complications occurred throughout including subperiosteal abscess (n = 39), venous sinus thrombosis (n = 10), and intracranial extension (n = 7). Partial or complete PCV vaccination was documented in 13 with S pneumoniae AM. Pneumococcal conjugate vaccine-13 use was not associated with a reduction in occurrence of AM compared with PCV-7. Research is needed to evaluate the effect of pneumococcal vaccines on AM incidence and complications.
No takes yet. Share an insight, caveat, or question.
Abdel‐Haq et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: